Shandong Taihe Pharmaceutical Technology Co., Ltd.

Main research purpose: According to the relevant provisions of bioequivalence test, AstraZeneca Pty Ltd was selected as the reference preparation for budesonide suspension for inhalation (trade name: Pulmicort Respules®, specification: 2ml:1mg), and the test preparation budesonide suspension for inhalation (specification: 2ml:1mg) provided by Shandong Taihe Pharmaceutical Technology Co., Ltd. was used for fasting human bioequivalence test, to compare whether the absorption rate and degree of the drug in the test preparation were within the acceptable range with the reference preparation, and to evaluate the bioequivalence of the two preparations under fasting conditions. Secondary research purpose: To observe the safety of oral inhalation of the test preparation budesonide suspension for inhalation (specification: 2ml:1mg) and the reference preparation budesonide suspension for inhalation (trade name: Pulmicort Respules®, specification: 2ml:1mg) in healthy subjects.